Lombardi Cancer Center — Washington D.C., District of Columbia

Lombardi Cancer Center is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Lombardi Cancer Center has participated in 57 clinical trials with 1 currently active.

Therapeutic areas: Colorectal Cancer, Unspecified Adult Solid Tumor, Protocol Specific, Leukemia.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, Prologue Research International.

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lombardi Cancer Center?

Lombardi Cancer Center has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lombardi Cancer Center conducted?

Lombardi Cancer Center has 57 clinical trials on record, with 1 currently active. Their work covers Colorectal Cancer, Unspecified Adult Solid Tumor, Protocol Specific, Leukemia.

Is Lombardi Cancer Center accredited by Crixeo Health?

Yes — Lombardi Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Lombardi Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.